Research & Innovation

Innovation
fueled by Passion

While supporting existing assets and developing new indications to address unmet needs, our Research & Development Department is focused on three main therapeutic areas: gastroenterology, vascular disease & neuroscience disorders.
Our new strategic plan deals with next decades challenges in healthcare, leveraging opportunities in precision medicine, maximizing existing competencies in microbiome, acquiring new assets in late stage development.
We are partnering with other organizations to exploit new opportunities through big data, new technologies, and patient engagement projects.

Read More

Mutual growth, transparency and patient centricity are the values that guide our dialogue with the medical community.
Reporting an adverse event is important in order to safeguard the patients who are taking it and ensure a favourable benefit-risk balance for the population.
Corporate Social Responsibility (CSR) is part of our company's DNA and constitutes one of its distinctive characteristics.
×

You’re entering Alfasigma global website

I agree